Clinical Trials Now Enrolling


BDTX-1535 FOR RECURRENT HIGH-GRADE GLIOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT06072586 to view inclusion criteria and additional study details.

Trial Screening

ONC201 IN NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT05580562 to view inclusion criteria and additional study details.

Trial Screening

Temsirolimus in Recurrent High-Grade Glioma

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT05773326 to view inclusion criteria and additional study details.

Trial Screening

AZD1390 FOR RECURRENT GLIOBLASTOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT05182905 to view inclusion criteria and additional study details.

Trial Screening

SONODYNAMIC THERAPY IN RECURRENT HIGH-GRADE GLIOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT04559685 to view inclusion criteria and additional study details.

Trial Screening

NIRAPARIB FOR NEWLY DIAGNOSED GLIOBLASTOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT05076513 to view inclusion criteria and additional study details.

Trial Screening

PAMIPARIB IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT04614909 to view inclusion criteria and additional study details.

Trial Screening

ABEMACICLIB PLUS LY3214996 FOR RECURRENT GLIOBLASTOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT04391595 to view inclusion criteria and additional study details.

Trial Screening Physician Information

RADIATION THERAPY FOR NEWLY DIAGNOSED ANAPLASTIC GLIOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT00887146 to view inclusion criteria and additional study details.

Trial Screening

RADIATION THERAPY VS. OBSERVATION FOR NEWLY DIAGNOSED MENINGIOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT03180268 to view inclusion criteria and additional study details.

Trial Screening